In business intelligence systems class (INFO 4555), students have the opportunity to analyze real business data from Cornell units for their end-of-semester project. This collaboration benefits both the students and the participating units.

While some COVID-19 patients can get very sick, others have barely any symptoms at all. A collaborative study between scientists at Stanford University and the Proteomics and Metabolomics Facility at the Cornell Institute of Biotechnology found that mildly and severely ill patients had different antibody signatures.

A brief descriptions of accomplishments for Monica Franciscus, Lynn Johnson, Zack Miller, Yaw Nti-Addae (5 years of service); Sara Miller, Jennifer Mosher, Elodie Smith (10 years); John Flaherty, Xiaoyun Wang (15 years); Cindy Wang (20 years); James VanEe (25 years).

Our Illumina NextSeq 2K sequencer is now available for placing orders.

New tools to study glycoproteins were created by Matt DeLisa, director of the Cornell Institute of Biotechnology, and his colleagues.

BioHPC is setting up a second Luster file system that is configured for speed and computing.

The study's objectives were to describe the serum proteome of newborn calves before and after colostrum feeding, and the possible effects of colostral heat treatment. Calves' innate immune defense pathways show important differences associated with colostrum ingestion. They also show that calves fed with heat-treated colostrum showed differences in serum proteins and enzymes associated with carbohydrate metabolism.

Discover the highlights of the BRC in this 2-minutes video.

All BRC facilities are now approved to resume services. We will share detailed changes to procedures, and timelines for the availability of services as soon as possible through mailings and on this website. We look forward to serving our research community as we move to a new (and evolving) normal during this phased process. The safety of our staff and the researchers who depend on our services is paramount. Throughout it all, we kindly ask for your continued patience and understanding.

Welcome you on our new website! If you encounter any issue, let us know by emailing us at: biotech-comm@cornell.edu